Our GPs can help you start Mounjaro or Wegovy if treatment is right for you. Repeats are requested online and delivered to your door, with GP review and support built in.

Join our newsletter and get £5 off your first booking.
Thanks — we've received your details.
If there's a next step for you, we'll send it by email.
Create your DocTap account with this email address to claim your £5 off. Offer available to new patients only. Unsubscribe whenever you like.
Injection prices cover four weekly doses. Wegovy tablet prices cover 30 tablets, taken once daily. Appointment fees are separate.
| Medication supply | Price |
|---|---|
| Wegovy 0.25mg injections | £98.98 |
| Wegovy 0.5mg injections | £118.97 |
| Wegovy 1mg injections | £148.97 |
| Wegovy 1.7mg injections | £178.97 |
| Wegovy 2.4mg injections | £198.97 |
| Mounjaro 2.5mg | £168.97 |
| Mounjaro 5mg | £188.97 |
| Mounjaro 7.5mg | £248.97 |
| Mounjaro 10mg | £278.97 |
| Mounjaro 12.5mg | £288.97 |
| Mounjaro 15mg | £298.97 |
| Wegovy 1.5 mg tablets — 30 tablets | £109 |
| Wegovy 4 mg tablets — 30 tablets | £119 |
| Wegovy 9 mg tablets — 30 tablets | £149 |
| Wegovy 25 mg tablets — 30 tablets | £199 |
Prescribing, repeats and delivery
Medication is prescribed only where suitable after a GP consultation. If prescribed, it is delivered to your door, and repeat prescriptions can be requested online with GP review.

Medication options
Mounjaro and Wegovy are prescription-only treatments for medical weight loss. Your GP will discuss the available options and help decide which is suitable for you.
Treatment options
Both are prescription-only treatments. The right option depends on your health, current medicines, treatment history and which routine you are most likely to follow consistently. Tablets are not automatically safer, easier or more effective than injections. Switching must always be planned by a prescriber; do not overlap treatments or calculate a switching dose yourself.
18 years or older. Treatment is not prescribed under 18. Caution is applied for patients over 75.
BMI of 30 kg/m² or more, or BMI of 27 kg/m² or more with at least one weight-related condition (for example hypertension, dyslipidaemia, obstructive sleep apnoea, prediabetes or Type 2 diabetes, PCOS, GORD, NAFLD, osteoarthritis). Ethnicity-adjusted thresholds apply for higher-risk groups.
Treatment is not prescribed in any of the following: • Pregnancy, planning pregnancy, or breastfeeding • Type 1 diabetes • Current use of insulin or sulfonylureas • Active use of another weight loss medication • Known allergy to the medication or its components • End-stage renal disease or dialysis • Active eating disorder • Severe unstable psychiatric illness • Active inflammatory bowel disease • Severe gastrointestinal disease or gastroparesis • Personal or family history of medullary thyroid cancer (Mounjaro) • MEN2 syndrome (Mounjaro) • Severe unstable retinopathy (Wegovy)
Ready to speak to a GP?
If you feel fully informed, book a consultation to discuss suitability and next steps with one of our GPs.